Taking
the tears out of asthma
Two
new concepts from leading European design
and development company, Cambridge Consultants
Ltd (CCL) aim to take the worry and stigma
out of being a child with asthma. The number
of children with asthma is growing. Already,
it affects one in ten children throughout
Europe, and the number of people recorded
with asthma has doubled in the past decade.
In
some countries such as Canada, Australia and
the UK, the prevalence of children suffering
with the disease is as high as 30%.
Despite these worrying statistics, childhood
asthma management can be improved. Children
can frequently be worried or stigmatised by
current treatment practices that involve the
use of a ‘spacer’ attached to
a normal asthma inhaler and consequently may
not use the device properly. Through the use
of innovative design, engineers at CCL intend
to make these drawbacks a thing of the past
and deliver better asthma treatment for children
across the world.
Successful treatment of asthma is directly
linked to correct usage of the inhaler and
its associated spacer, and the willingness
of the child to use the apparatus. Many children
up to the age of 15, but especially those
under the age of 5, are unable to co-ordinate
activating the inhaler and simultaneously
breathing. Further, they often cannot manage
to achieve the required minimum respiratory
flow that allows the drug to be successfully
delivered to the affected area of lung and
bronchial tract. Spacers help children to
get over both of these problems although,
with being a large balloon-like piece of hollow
transparent plastic, many find them cumbersome
to carry around and they can worry small children
when they first learn to use them. It is not
unknown for children to carry a packed-lunch
box just to transport their spacer, although
the very process of doing so can mark them
out from other children.
Engineers in CCL’s Drug Delivery group
set about tackling the problem of how to make
spacers appealing to children under the age
of 15 whilst retaining device efficacy for
successful treatment. CCL’s philosophy
is that sources of innovation are all around
us, but that you just need to know where to
look. To tackle this problem the team turned
to children’s toys, the ancient art
of origami, and a toddler’s teaspoon
to create a range of new concepts.
For hundreds of years the Japanese have been
folding paper into decorative and useful shapes.
Using similar principles Cambridge Consultants
has designed a low cost collapsible spacer
that allows patients to keep their spacer
in their pocket. The spacers can be made from
card or plastic and they offer significant
benefits in a low cost device. Designs, or
images of the latest super-hero or pop star
could be printed onto the spacers so as to
increase the attractiveness of the device.
With a product made from card, and therefore
disposable on a weekly basis, the design can
even keep pace with children’s quickly
changing tastes and trends.
Another idea was inspired by a ‘Jack
in the Box’. A spring-loaded spacer
has been designed that in its open state offers
all the benefits of a standard spacer but
by compressing the spring the patient is able
to store the compact device in their pocket.
Further designs have been created to improve
the image of spacers and increase their attractiveness
to children. One such design uses thermochromatic
plastics that change colour with temperature.
These plastics are used in some children’s
teaspoons to cause the spoon to change colour
indicating the food is still too hot. Manufacturing
the spacers out of these plastics allows the
use of the spacer to be rewarded with the
appearance of images or patterns as the body
heat increases the temperature of the plastic.
Jon Tuckwell, who heads CCL’s Drug Delivery
Group commented, "With as many as one
in three children suffering with asthma, I’m
amazed that little has been done to improve
the problems associated with using a spacer.
Whilst the disease is well understood and
can be well treated, it is critical that the
child is willing to use the delivery device.
If they are unwilling to be seen carrying
or using a spacer then they simply will not
be getting the treatment they need. We know
that certain devices,
such as mobile phones, are seen as the ‘cool’
accessories to have in the playground. My
aim in this development is to take the cool
elements and apply them to this problem."
The
combination of science and design techniques
to create new designs such as those described
above has been shown to greatly improve the
appeal of the spacers. The result is improved
delivery of drug to the lungs, reduced systemic
side effects and hence better asthma management
for children across the world. Cambridge Consultants
is currently discussing its patented concepts
with a number of leading healthcare companies.
Initial research into the problems associated
with treating children with asthma was conducted
with the valuable support of the asthma nurses
at Addenbrooke’s Hospital.
Downloadable
images are available from our media
centre
Some
Facts About Asthma
-
With 100-150 million people with Asthma
world-wide, the WHO (World Health Organisation)
estimate that more than 180,000 people die
from it each year.
-
Each year in the United States 150,000 children
are hospitalised by their asthma and almost
5,000 children die from their condition;
National Vital Statistics Reports, Vol.
49, No. 8, CDC
-
In
the USA Asthma is the third leading cause
of hospitalisation among children under
the age of 15 and it is the first-ranking
chronic condition; American Lung Association
-
In the USA, Asthma accounts for 14 million
lost school days annually. It is the leading
cause of school absenteeism attributed to
chronic conditions, and the estimated annual
cost of treating asthma in those under 18
years of age is $3.2 billion; American Lung
Association
-
5.1 million people in the UK are currently
receiving treatment for asthma: 1.4 million
children (1 in 8) and 3.7 million adults
(1 in 13); National Asthma Campaign
-
On average 1,500 people die from asthma
each year in the UK – at least a third
of those are under the age of 65. This is
four people per day, or one person every
six hours ; National Asthma Campaig
-
Every 16 minutes a child is admitted to
hospital in England, Scotland or Wales because
of their asthma; National Asthma Campaign
-
The UK has the highest prevalence of severe
wheeze in children aged 13–14 years
worldwide; National Asthma Campaign
Notes for editors:
Cambridge Consultants Limited (CCL) designs
and develops innovative new products, processes
and systems. The organization enables clients
to turn business opportunities into commercial
successes, whether launching first-to-market
products, or expanding existing markets through
the introduction of new technologies. With a
team of over 250 engineers and scientists, CCL
is able to offer solutions across a diverse
range of industries including healthcare, telecommunications,
industrial and consumer products, automotive
and aerospace. Operating from purpose-built
laboratories on the Cambridge Science Park,
CCL works for multinationals and small companies
alike.
|